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CLINICAL EFFECT OF ALLYLESTRENOL （GESTANON） ON
 PATIENTS WITH BENIGN PROSTATIC HYPERTROPHY
 WITIH REFERENCE TO ESTIMATION OF SIZE AND WEIGHT OF THE
PROSTATE BY MEANS OF TRANSRECTAL ULTRASONOTOMOGRAPHY一
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       （Chairmanr Prof． K． lmamura， M． D．）
  Nine patients with benign prostatic hypertrophy were treated with a progestatipnal agent，
AHylestrenol （Gestanon）， 30 mg daily for three months to one year． As the control， IO patients
with prostatic hypertrophy were treated with Eviprostat， a non－hormonal remedy consisting
of plant extracts， 6 tablets daily for the same duration．
  Subjective symptoms of 7 patients who had received Eviprostat and those of 8 patients
who had received Gestanon were improved significantly． There was no reduction in size or
weight of the prostate after three months to one year of treatment with Eviprostat， as measured
by transrectal ultrasonotomography， but remarkable reduction in size and weight of the
prostate was observed after three months in 6 of the patients treated with Gestanon． The
prostate continued to be reduced gradually for one year． There were no side effects following
administration of Gestanon．
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17α一allyl－17β一hydroxy－estr－4－ene

























（34．6 g） Fig． 2
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